![Royston Glasspool](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Royston Glasspool
Direktor/Vorstandsmitglied bei RELMADA THERAPEUTICS, INC.
Vermögen: - $ am 31.05.2024
Aktive Positionen von Royston Glasspool
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
RELMADA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 19.12.2019 | - |
Independent Dir/Board Member | 19.12.2019 | - | |
Biotechnology Innovation Organization
![]() Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Direktor/Vorstandsmitglied | - | - |
DalCor Pharmaceuticals Canada, Inc.
![]() DalCor Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology DalCor Pharmaceuticals Canada, Inc. develops precision treatments for cardiovascular diseases. It offers dalcetrapib, a cholesterol ester transfer protein (CETP) inhibitor, as a potential targeted treatment to address the residual cardiovascular risk in patients carrying a specific ADCY9 genetic profile. The company was founded by Andr? Roger Desmarais and is headquartered in Montreal, Canada. | Direktor/Vorstandsmitglied | 01.05.2017 | - |
Independent Dir/Board Member | 01.05.2017 | - | |
Agent Capital LLC
![]() Agent Capital LLC Investment ManagersFinance Agent Capital LLC (Agent Capital) is a venture capital firm founded in 2017 by Geeta Vemuri. The firm is headquartered in Waltham, Massachusetts. | Private Equity Investor | 01.01.2018 | - |
Karriereverlauf von Royston Glasspool
Ehemalige bekannte Positionen von Royston Glasspool
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Anthos Therapeutics, Inc.
![]() Anthos Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Anthos Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that develops and commercializes innovative therapies for high-risk cardiovascular patients. It offers MAA868, an antibody directed at Factor XI and XIa, key components of the intrinsic coagulation pathway. The company was founded by Paris Panayiotopoulos, Ari Brettman and Jonathan E. Freeman in 2018 and is headquartered in Cambridge, MA. | Direktor/Vorstandsmitglied | 01.02.2019 | 22.04.2024 |
Vorstandsvorsitzender | 01.02.2019 | 22.04.2024 | |
BAXALTA INC | Corporate Officer/Principal | 01.07.2015 | 01.01.2017 |
BAXTER INTERNATIONAL INC. | Corporate Officer/Principal | 01.08.2012 | 01.06.2015 |
European Vaccine Manufacturers | Direktor/Vorstandsmitglied | 01.01.2010 | 01.12.2012 |
Corporate Officer/Principal | 01.01.2010 | 01.12.2012 | |
NOVARTIS AG | Corporate Officer/Principal | 01.01.2002 | 01.08.2012 |
Ausbildung von Royston Glasspool
Oxford Brookes University | Undergraduate Degree |
Staffordshire University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 7 |
Vereinigtes Königreich | 3 |
Kanada | 2 |
Operativ
Director/Board Member | 5 |
Corporate Officer/Principal | 4 |
Independent Dir/Board Member | 2 |
Sektoral
Health Technology | 7 |
Consumer Services | 3 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
RELMADA THERAPEUTICS, INC. | Health Technology |
NOVARTIS AG | Health Technology |
BAXTER INTERNATIONAL INC. | Health Technology |
Private Unternehmen | 6 |
---|---|
Biotechnology Innovation Organization
![]() Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
DalCor Pharmaceuticals Canada, Inc.
![]() DalCor Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology DalCor Pharmaceuticals Canada, Inc. develops precision treatments for cardiovascular diseases. It offers dalcetrapib, a cholesterol ester transfer protein (CETP) inhibitor, as a potential targeted treatment to address the residual cardiovascular risk in patients carrying a specific ADCY9 genetic profile. The company was founded by Andr? Roger Desmarais and is headquartered in Montreal, Canada. | Health Technology |
Anthos Therapeutics, Inc.
![]() Anthos Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Anthos Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that develops and commercializes innovative therapies for high-risk cardiovascular patients. It offers MAA868, an antibody directed at Factor XI and XIa, key components of the intrinsic coagulation pathway. The company was founded by Paris Panayiotopoulos, Ari Brettman and Jonathan E. Freeman in 2018 and is headquartered in Cambridge, MA. | Health Technology |
Baxalta, Inc.
![]() Baxalta, Inc. BiotechnologyHealth Technology Baxalta, Inc. engages in the research, development, and manufacture of biopharmaceutical products. Its portfolio includes treatments for hemophilia, bleeding disorders, immune deficiencies, alpha-1 antitrypsin deficiency, burns, and shock. The company was founded on March 13, 2015 and is headquartered in Chicago, IL. | Health Technology |
European Vaccine Manufacturers | |
Agent Capital LLC
![]() Agent Capital LLC Investment ManagersFinance Agent Capital LLC (Agent Capital) is a venture capital firm founded in 2017 by Geeta Vemuri. The firm is headquartered in Waltham, Massachusetts. | Finance |
- Börse
- Insiders
- Royston Glasspool
- Erfahrung